A Phase I Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers.
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2014
At a glance
- Drugs Everolimus (Primary) ; Topotecan
- Indications Endometrial cancer
- Focus Adverse reactions
- 13 Jan 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Dec 2008 Actual start date ( Dec 2008) added as reported by ClinicalTrials.gov.
- 02 Dec 2008 Planned end date changed from 1 Oct 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.